Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of< 1.00 g/l in high cardiovascular risk patients …
N Danchin, R Chadarevian, JL Gayet… - … de Cardiologie et D' …, 2007 - europepmc.org
Many patients at high cardiovascular risk still fail to achieve recommended LDL-C goals.
Showing evidence of a difference between two statins at the same dose can significantly …
Showing evidence of a difference between two statins at the same dose can significantly …
Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel …
AS Binbrek, A Elis, M Al-Zaibag, J Eha, I Keber… - Current therapeutic …, 2006 - Elsevier
BACKGROUND:: The majority of clinical trials investigating the clinical benefits of lipid-
lowering therapies (LLTs) have focused on North American or western and nothern …
lowering therapies (LLTs) have focused on North American or western and nothern …
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals
M Hirsch, J O'donnell, A Olsson - International journal of cardiology, 2005 - Elsevier
BACKGROUND: Lowering low-density lipoprotein cholesterol (LDL-C) levels reduces the
risk of coronary heart disease. The introduction of a highly efficacious new statin …
risk of coronary heart disease. The introduction of a highly efficacious new statin …
Superior benefit of aggressive lipid-lowering therapy for high-risk patients using statins: the SUBARU study—more hypercholesterolemic patients achieve Japan …
M Kurabayashi, T Yamazaki… - … of atherosclerosis and …, 2008 - jstage.jst.go.jp
Aim: There have been few comparisons between rosuvastatin and other statins in Japanese
patients. This open-label, randomized, parallel-group comparative study was performed to …
patients. This open-label, randomized, parallel-group comparative study was performed to …
Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database
MK Palmer, SJ Nicholls, P Lundman… - European journal of …, 2013 - academic.oup.com
Background Reducing low-density lipoprotein cholesterol (LDL-C) levels decreases
cardiovascular risk in direct proportion to the decrease in LDL-C. Design The aim of this …
cardiovascular risk in direct proportion to the decrease in LDL-C. Design The aim of this …
A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of …
J Zhu, B Tomlinson, YM Ro, KH Sim… - … medical research and …, 2007 - Taylor & Francis
Background: Most studies investigating the benefits of statins have focused on North
American and European populations. This study focuses on evaluating the lipid-lowering …
American and European populations. This study focuses on evaluating the lipid-lowering …
Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from …
SJ Nicholls, G Brandrup-Wognsen, M Palmer… - The American journal of …, 2010 - Elsevier
Statins are the most commonly prescribed agents for lowering levels of low-density
lipoprotein (LDL) cholesterol. Although dose-dependent reductions in levels of atherogenic …
lipoprotein (LDL) cholesterol. Although dose-dependent reductions in levels of atherogenic …
[HTML][HTML] EFFECTIVENESS OF ROSUVASTATIN IN VERY HIGH RISK CARDIOVASCULAR PATIENTS IN THE ACTUAL OUTPATIENT PRACTICE
VP Mikhin, DV Nebieridze… - Cardiovascular …, 2015 - cardiovascular.elpub.ru
Aim. To evaluate the comparative efficacy of Rosivastatin (Rosart) and atorvastatin in
patients with very high grade of cardiovascular risk (CVR), arterial hypertension (AH) and …
patients with very high grade of cardiovascular risk (CVR), arterial hypertension (AH) and …
Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis
A Middleton, AS Binbrek, FAH Fonseca… - … medical research and …, 2006 - Taylor & Francis
Background: There is an increasing body of evidence to support the benefits of reducing low-
density lipoprotein cholesterol (LDL-C) levels and this has been reflected in a lowering of …
density lipoprotein cholesterol (LDL-C) levels and this has been reflected in a lowering of …
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
PH Jones, MH Davidson, EA Stein, HE Bays… - The American journal of …, 2003 - Elsevier
The primary objective of this 6-week, parallel-group, open-label, randomized, multicenter
trial was to compare rosuvastatin with atorvastatin, pravastatin, and simvastatin across dose …
trial was to compare rosuvastatin with atorvastatin, pravastatin, and simvastatin across dose …